CD4-dependent generation of dominant transplantation tolerance induced by simultaneous perturbation of CD154 and LFA-1 pathways

Journal of Immunology

Volumn 169, Issue 9, 2002, Pages 4831-4839

  Nicolls, Mark R ^a   Coulombe, Marilyne ^a   Beilke, Joshua ^a   Gelhaus, H Carl ^a   Gill, Ronald G ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD40 LIGAND; CD40 LIGAND MONOCLONAL ANTIBODY; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY LFA 1; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ALLOGRAFT; ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG TARGETING; GRAFT SURVIVAL; IMMUNOREGULATION; IMMUNOTHERAPY; MONOTHERAPY; MOUSE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; T LYMPHOCYTE; TRANSPLANTATION TOLERANCE;

EID: 0036839226     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.9.4831     Document Type: Article

References (62)

1. Shapiro, A. M. J., J. R. T. Lakey, E. A. Ryan, G. S. K. Korbutt, E. Toth, G. L. WArnock, N. M. Kneteman, and R. V. Rajotte. 2000, Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosupressive regimen, N. Engl. J. Med. 343:230.
2. Shizuru, J. A., A. K. Gregory, C. T. B. Chao, and C. G. Fathman. 1987. Islet allograft survival after a single course of treatment of recipient with antibody to L3T4. Science 237:278.
3. Song, H. K., S. E. Alters, and C. G. Fathman, 1993. Evidence that anti-CD8 abrogates anti-CD4-mediated clonal anergy but allows allograft survival in mice. Transplantation 55:133.
4. Nicolls, M. R., M. Colulombe, H, Yang, A. Bolwerk, and R. G. Gill. 2000. Anti-LFA-1 therapy induces long term islet allograft acceptance in the absence of IFN-γ or IL-4, J. Immunol. 164:3627.
5. Parker, D. C., D. L. Greiner, N. E. Phillips, M. C. Appel, A. W. Steele, F. H. Durie, R. J. Noelle, J. P. Mordes, and A. A. Rossini. 1995. Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand. Proc. Natl. Acad. Sci. USA 92:9560.
6. Auersvald, L. A., D. M. Rothstein, S. C. Oliveira, C. Q. Khuong, H. Onodera, A. I. Lazarovits, and G. P. Basadonna, 1997. Indefinite islet allograft survival in mice after a short course of treatment with anti-CD45 monoclonal antibodies. Transplantation 63:1355.
7. Tran, H. M., P. W. Nickerson, A. C. Restifo, M. A. Ivis-Woodward, A. Patel, R. D. Allen, T. B. Strom, and P, J, O'Connell. 1997. Distinct mechanisms for the induction and maintenance of allograft tolerance with CTLA4-Fc treatment. J. Immunol. 159:2232.
8. Sanchez-Fueyo, A., M. Weber, C. Domenig, T. B. Strom. and X. X, Zheng. 2002. Tracking the immunoregulatory mechanisms active during allograft tolerance, J. Immunol. 168:2274.
9. Qin, S., S. P. Cobbold, H. Pope, J. Elliott, D. Kioussis, J. Davies, and H. Waldmann. 1993. "Infectious" transplantation tolerance. Science 259:974.
10. + T cell tolerance and linked suppression. J. Immunol. 163:4805.
11. Larsen, C. P., E. T. Elwood, D. Z. Alexander, S. C. Ritchie, R. Hendrix, C. Tucker-Burden, H. R. Cho, A. Aruffo, D. Hollenbaugh, P. S. Linsley, K. J. Winn, and T. C. Pearson, 1996. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 381:434.
12. + T cells play a critical role in costimulation blockade-resistant allograft rejection. J. Clin. Invest. 104:1715.
13. + cells and CD40-CD40 ligand interactions. J. Immunol. 166:3248.
14. Oh, C., R. Stratta, B. Fox, H, Sollinger. F. Belzer, and D. Maki. 1988. Increased infections associated with the use of OKT3 for treatment of steroid-resistant rejection in renal transplantation. Transplantation 45:68.
15. Curtis, R., L, Travis, P. Rowlings, G. Socie, D. Kingma, P. Banks. E. Jaffe, G. Sale, M. Horowitz, R. Witherspoon, et al. 1999. Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood 94:2208.
16. Jamil, B., K. Nicholls, G. Becker, and R. Walker. 2000. Influence of anti-rejection therapy on the timing of cytomegalovirus disease and other infections in renal transplant recipients. Clin Transplant. 14:14.
17. Storek, J., T. Gooley, R. Witherspoon, K. Sullivan, and R. Storb. 1997, Infectious morbidity in long-term survivors of allogeneic marrow transplantation is associated with low-CD4 counts. Am. J. Hematol. 54:131.
18. + T-lymphocyte counts during Pneumocystis carinii pneumonia patients without HIV infection. Chest 118:712.
19. Dialynas, D. P., D. B. Wilde, P. Marrack, A. Pierres, K. A. Wall, W. Havran, G. Otten, M. R. Loken, M. Pierres, J. Kappler, and F. W. Fitch. 1983. Characterization of the murine antigenic determinant, designated L3T4a. recognized by monoclonal antibody GK1.5: expression of L3T4a by functional T cell clones appears to correlate primarily with class 11 MHC antigen-reactivity. Immunol. Rev. 74:29.
20. Kranz, D. M., D. H. Sherman, M. V. Sitkovsky, M. S. Pastemack. and H. N. Eisen. 1984. Immunoprecipitation of cell surface structures of cloned cytotoxic T lymphocytes by clone-specific antisera. Proc. Natl. Acad. Sci. USA 81:573.
21. Sarmiento, M., D. P. Dialynas, D. W. Lancki, K. A. Wall, M. I. Lorber, M. R. Loken, and F. W. Fitch. 1982. Cloned T lymphocytes and monoclonal antibodies as probes for cell surface molecules active in T cell mediated cytolysis. Immunol. Rev. 68:135.
22. Nicolls, M. R., M. Coulombe, A. S. Diamond, J. Beilke, and R. G. Gill, 2002. Interferon-γ is not a universal requirement for islet allograft survival. Transplantation 74:472.
23. Springer, T. 1990, Adhesion receptors of the immune system, Nature 346:425.
24. Kooten, C. V., and J. Banchereau. 1996. CD40-CD40 ligand: A multifunctional receptor-ligand pair. Adv. Immunol. 61:1.
25. Coulombe, M., and R. G. Gill., 1994. Tolerance induction to cultured islet allografts. I. Characterization of the tolerant state. Transplantation 57:1195.
26. Coulombe, M., and R. G. Gill. 1996. T lymphocyte indifference to extrathymic islet allografts. J. Immunol. 156:1998.
27. Sha, W. C., C. A. Nelson, R. D. Newberry, D. M. Kranz, J. H. Russell, and D. Y. Loh. 1988. Selective expression of an antigen receptor on CD8-bearing T lymphocytes in transgenic mice. Nature 335:271.
28. Stegall, M. D., M. Elices, G. Shepard, C. Gup, D. Ninova, D. Ferguson, and R. G. Gill. 1999. The 2C T-cell transgenic mouse: An in vivo model ofallospecific cytotoxic T-cell activation and homing. Transplant. Proc. 31:779.
29. + T cell-mediated rejection of pancreatic islet allografts. J. Immunol. 165:247.
30. Isobe, M., H. Yagita, K. Okumura, and A. Ihara. 1992. Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1. Science 255:1125.
31. Kirk, A. D., D. M. Harlan, N. N. Armstrong, T. A. Davis, Y. Dong, G. S. Gray, X. Hong, D. Thomas, J. H. Fechner, Jr., and S. J. Knechtle. 1997. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc. Natl. Acad. Sci. USA 94:8789.
32. + T cells, interferon-γ, and CTLA4. J. Clin. Invest. 101:2446.
33. Campos, L., A. Naji, B. C. Deli, J. H. Kern, J. I. Kim, C. F. Barker, and J. F. Markmann. 1995. Survival of MHC-deficient mouse heterotopic cardiac allografts. Transplantation 59:187.
34. Pietra, B. A., A. Wiseman, A. Bolwerk, M. Rizeq, and R. G. Gill. 2000. CD4 T cell-mediated cardiac allograft rejection requires donor but not host NHC class II. J. Clin. Invest. 106:1003.
35. + T lymphocyte-deficient mice. Transplantation 55:718.
36. + regulatory cells. Immunity 14:399.
37. + cells in vitro and in vivo. Immunol. Rev. 91:195.
38. Williams, M., J. Trambley, J. Ha, A. Adams, M. Durham, P. Rees, S. Cowan, T. Pearson, and C. Larsen. 2000. Genetic characterization of strain differences in the ability to mediate CD40/CD28-independent rejection of skin allografts. J. Immunol. 165:6849.
39. + T cell peripheral tolerance in nonobese diabetic mice. J. Immunol. 167:1112.
40. Krensky, A., F. Sanchez-Madrid, E. Robbins, J. Nagy, T. Springer, and S. Burakoff. 1983. The functional significance, distribution, and structure of LFA-1, LFA-2, and LFA-3: Cell surface antigens associated with CTL-target interactions. J. Immunol. 131:611.
41. Ware, C., F. Sanchez-Madrid, A. Krensky, S. Burakoff, J. Strominger, and T. Springer. 1983. Human lymphocyte function associated antigen (LFA-1): Identification of multiple antigenic epitopes and their relationship to CTL-mediated cytotoxicity, J. Immunol. 131:1182.
42. Corbascio, M., H. Mahanty, C. Osterholm, Z. Qi, T. C. Pearson, C. P. Larsen, C. E. Freise, and H. Ekberg. 2002. Anti-lymphocyte function-associated antigen-1 monoclonal antibody inhibits CD40 ligand-independent immune responses and prevents chronic vasculopathy in CD40 ligand-deficient mice. Transplantation 74:35.
43. Waldmann, H. 1999. Transplantation tolerance: where do we stand? Nat. Med. 5:1245.
44. Li, Y., X. Li, X. Zheng, A. Wells, L. Turka, and T. Strom. 1999. Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance. Nat. Med. 5:1298.
45. Wells, A. D., X. C. Li, Y. Li, M. C. Walsh, X. X. Zheng, Z. Wu, G. Nunez, A. Tang, M. Sayegh, W. W. Hancock, T. B. Strom, and L. A. Turka. 1999. Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance. Nat. Med. 5:1303.
46. + T cells and prolonged graft survival in a CTLA4-dependent manner. J. Immunol. 164:512.
47. Iwakoshi, N., T. Markees, N. Turgeon, T. Thornley, A. Cuthbert, J. Leif, N. Phillips, J. Mordes, D. Greiner, and A. Rossini. 2001. Skin allograft maintenance in a new synchimeric model of system of tolerance. J. Immunol. 167:6623.
48. Graca, L., K. Honey, E. Adams, S. P. Cobbold, and H. Waldman. 2000. Anti-CD154 therapeutic antibodies induce infectious transplantation tolerance. J. Immunol. 165:4783.
49. Nishihara, M., M. Gotoh, H. Ohzato, Y. Ohta, Z.-J. Luo, K. Dono, K. Umeshita, M. Sakon, M. Monden, H. Yagita, K. Okumura, and M. Miyasaka. 1997. Awareness of donor alloantigens in antiadhesion therapy induces antigen-specific unresponsiveness to islet allografts. Transplantation 64:965.
50. Van Seventer, G. A., Y. Shimizu, K. J. Horgan, and S. Shaw. 1990. The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells. J. Immunol. 144:4579.
51. Ni, H. T., M. J. Deeths, W. Li, D. L. Mueller, and M. F. Mescher. 1999. Signaling pathways activated by leukocyte function-associated Ag-1-dependent costimulation. J. Immunol. 162:5183.
52. + T cell proliferation requires phosphatidylinositol 3-kinase activity. J. Immunol. 166:6523.
53. + T cells. Proc. Natl. Acad. Sci. USA 98:241.
54. Hall, B. M. 1985. Mechanisms maintaining enhancement of allografts. I. Demonstration of a specific suppressor cell. J. Exp. Med. 161:123.
55. Hall, B. M., M. E. Jelbart, K. E. Gurley, and S. E. Dorsch. 1985. Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine: Mediation of specific suppression by T helper/inducer cells. J. Exp. Med. 162:1683.
56. + T cells. J. Immunol. 144:3288.
57. + T cells. J. Exp. Med. 178:237.
58. Sakaguchi, S., N. Sakaguchi, M. Asano, M. Itoh, and M. Toda. 1995. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). J. Immunol. 155:1151.
59. Hara, M., C. Kingsley, M. Niimi, S. Read, S. Turvey, A. Bushell, P. Morris, F. Powrie, and K. Wood. 2001. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J. Immunol. 3789.
60. Honey, K., S. P. Cobbold, and H. Waldmann. 2000. Dominant tolerance and linked suppression induced by therapeutic antibodies do not depend on Fas-FasL interactions. Transplantation 69:1683.
61. Homann, D., A. Jahreis, T. Wolfe, A. Hughes, B. Coon, M. J. van Stipdonk, K. R. Prilliman, S. P. Schoenberger, and M. G. von Herrath. 2002. CD40L blockade prevents autoimmune diabetes by induction of bitypic NK/DC regulatory cells. Immunity 16:403.
62. Marshall, S. E., S. P. Cobbold, J. D. Davies, G. M. Martin, J. M. Phillips, and H. Waldmann. 1996. Tolerance and suppression in a primed immune system. Transplantation 62:1614.